Technical Analysis for SLN - Silence Therapeutics Plc
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Up | Down | Down |
| Historical SLN trend table... | |||
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Non-ADX 1,2,3,4 Bearish | Bearish Swing Setup | 0.00% | |
| Narrow Range Bar | Range Contraction | 0.00% | |
| NR7 | Range Contraction | 0.00% | |
| Inside Day | Range Contraction | 0.00% | |
| Lower Bollinger Band Walk | Weakness | -1.27% | |
| Slingshot Bearish | Bearish Swing Setup | 1.88% | |
| Stochastic Buy Signal | Bullish | 1.88% | |
| Lower Bollinger Band Walk | Weakness | 1.88% | |
| Lower Bollinger Band Touch | Weakness | 1.88% | |
| Oversold Stochastic | Weakness | 1.88% |
Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App
| Alert | Time |
|---|---|
| No Alerts Yet. Alerts will only show here if at least one person is tracking alerts on this stock. | |
Get a Trading Sidekick!
Silence Therapeutics Plc Description
Silence Therapeutics plc is a United Kingdom-based ribonucleic acid (RNA) technology company. The Company is primarily involved in the research and development of pharmaceutical products. The Company's technology harnesses the body's natural mechanisms to create therapeutic effects within its own cells. The Company has a has a genetic toolkit with its own therapeutic payloads to modulate gene expression up as well as down in preclinical in vivo models, and delivery systems for various organs and cell types. The Company's RNA interference (RNAi) platform is AtuRNAi. AtuRNAi is based on specific small interfering RNA (siRNA) modules, stabilization technology and other tailored features. The Company's technology is in the clinic in a Phase IIa pancreatic cancer trial. The Company has developed modifications to improve the robustness of RNA sequences, together with advanced liposomal chemistries to enhance the delivery of therapeutic RNA molecules.
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Research Pharmaceutical Clinic Cancer Branches Of Biology IPO Biology Tailor Molecular Biology Pharmaceutical Products Sms Genetics Organs Molecular Genetics Therapeutic Effect
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 668.0 |
| 52 Week Low | 330.0 |
| Average Volume | 48,604 |
| 200-Day Moving Average | 487.86 |
| 50-Day Moving Average | 577.46 |
| 20-Day Moving Average | 554.75 |
| 10-Day Moving Average | 546.50 |
| Average True Range | 28.07 |
| ADX | 14.87 |
| +DI | 17.70 |
| -DI | 19.53 |
| Chandelier Exit (Long, 3 ATRs ) | 515.79 |
| Chandelier Exit (Short, 3 ATRs ) | 576.51 |
| Upper Bollinger Band | 591.86 |
| Lower Bollinger Band | 517.64 |
| Percent B (%b) | 0.34 |
| BandWidth | 13.38 |
| MACD Line | -10.35 |
| MACD Signal Line | -8.79 |
| MACD Histogram | -1.5658 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 557.27 | ||||
| Resistance 3 (R3) | 557.85 | 553.68 | 554.89 | ||
| Resistance 2 (R2) | 553.68 | 550.05 | 553.39 | 554.09 | |
| Resistance 1 (R1) | 548.34 | 547.80 | 546.26 | 547.76 | 553.30 |
| Pivot Point | 544.17 | 544.17 | 543.13 | 543.88 | 544.17 |
| Support 1 (S1) | 538.83 | 540.54 | 536.75 | 538.25 | 532.70 |
| Support 2 (S2) | 534.66 | 538.29 | 534.37 | 531.91 | |
| Support 3 (S3) | 529.32 | 534.66 | 531.11 | ||
| Support 4 (S4) | 528.74 |
